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Heating of pacemaker leads during
magnetic resonance imaging
Is MRI contraindicated in PM-patients? In
their carefully performed study, Luechinger
et al.1 convincingly show the possible
heating of pacemaker leads by measuring
heating at the lead tip together with the
pacing parameters. Heating, comparable
with in vitro data, occurred in the presence
of blood ﬂow. Therefore, protection by the
cooling effect of myocardial blood ﬂow in
any in vivo or clinical setting is small and
must no longer be overestimated.
They speculate about the clinical signiﬁ-
cance and state that there is a lack of
follow-up data with respect to signiﬁcant
threshold changes. Our follow-up data
showed that battery current and impe-
dance only tended to increase. The calcu-
lated rest of function time did not change
nor was any signiﬁcant threshold altera-
tion with the need to modify programmed
data observed.2
The heating problem may be even more
pronounced in the clinical setting. The
chest anatomy of swine, even if weighing
60–65 kg, does not resemble that in
humans. The difference in radius of
the semicircle lead conﬁguration in the
coronal plane may lead to heating effects
of greater extent in humans. Heating is
considered to be especially problematic
when objects are conﬁgured in a loop or
coil, as conducting loops are known to
provide a high current density in low impe-
dance, metallic, conductive materials.3
It is up to the reader to decide whether
it is beside the point to present an edi-
torial comment in an animal study paper
that could be understood as a recommen-
dation for clinicians planning to perform
MRI scans in pacemaker patients. In a
clinical setting, our recommendation is
different. If the referring physician, the
radiologist, and the cardiologist agree
that MRI is an urgent diagnostic necessity
without an acceptable imaging alternative
in a patient with cardiac pacemaker,
certain requirements have to be met.
Written informed consent of the patient
is needed. To reduce the risk of thermal
injury during MRI, RF-exposure and
sequence time have to be minimized.
Like monitoring of systemic haemody-
namics and cardiac rhythm with MRI com-
patible devices, cardiological standby for
online analysis of cardiac rhythm and
standby for immediate cardiopulmonary
resuscitation belong to the minimal pre-
cautions. A complete pacemaker check
including interrogation, evaluation of
intrinsic rhythm, sensing thresholds,
stimulation thresholds, lead impedance,
and battery voltage is mandatory before
and immediately after MRI. Additional
assessments, i.e. 4 weeks following MRI,
are recommended.
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Heating of pacemaker leads during
magnetic resonance imaging: reply
We appreciate Dr Vahlhaus’ interest in our
paper.1 We agree that heating at the lead
tip–myocardium interface may not signiﬁ-
cantly decrease due to the cooling effect.
However, this is only valid for the chroni-
cally implanted leads. In the acute setting,
scar formation is not prominent and the
cooling effects may be more pronounced.
In addition, in our study, we did not
intend to make a direct comparison
between the in vitro and in vivo settings,
as lead conﬁgurations and positions were
not identical.
We absolutely agree with Dr Vahlhaus’
comments concerning the anatomical
differences between pigs and humans,
as mentioned in our study limitations.
However, the pig model is much more
representative of the human anatomy,
when compared with canines with a
smaller torso, as used in the recently pub-
lished paper by Roguin et al.2 In our study,
the pacemaker leads were implemented
with loops comparable with those seen in
the humans. Therefore, we do not expect
any systematic underestimation of the
heating problem. Nevertheless, we agree
that special lead conﬁgurations may result
in higher heating effects. In addition,
other positions in the bore may result in
higher temperatures as shown in Figure 2
in our paper.
Our paper does not serve the purpose of
an overall recommendation for safe MRI
procedures in pacemaker recipients, but
to show the realistic temperature excur-
sion in vivo to allow interpretation by
physiologic accepted temperature limits
used by safety requirements. We fully
agree with Dr Vahlhaus that this study
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and the editorial should not be inter-
preted as a recommendation for clinicians
to perform MRI in pacemaker patients.
The diagnostic need for an MRI has to be
evaluated individually for each patient,
and if there is an urgent necessity and in
the absence of an alternative imaging
modality, MRI may be considered with
the precautions and follow-up measures
as recommended by Dr Vahlhaus, in
accordance with our paper.
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